INLET STRATEGIES

Lobbying for COHERUS BIOSCIENCES, INC · pharmaceutical development

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 18, 2026

Lobbying activity 2

Health Issues

Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry

Medicare/Medicaid

Federal Financial Support for the American Biotech Industry

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.